| Revenue Growth | U.S. revenue $53.2M (up 14.7%); International $2.8M (up 25.9%). |
|---|---|
| Mgmt Confidence | High confidence in 2027 momentum from new products and reimbursement tailwinds. |
| Demand Visibility | Strong sequential U.S. procedure volume growth of 9% in Q2. |
| Margin Trends | Gross margin stable at 79.5%; adjusted EBITDA improved 178% to $2.8M. |
| Op. Leverage | Revenue grew twice as fast as operating expenses (7.7% expense growth). |
| Pricing Power | Stable ASPs; guidance assumes low single-digit degradation from product mix shifts. |
| Vol vs Price | Growth led by 15% U.S. procedure volume increase; ASPs remained stable. |
| Segment Growth | Double-digit growth in SI joint fusion, pelvic fixation, and pelvic trauma. |
| New Clients | Active physicians grew 19% to 1,715; Smith & Nephew partnership progressing. |
| Capex & Debt | $145.9M cash; investing in surgical capacity and new headquarters build-out. |
| Regulatory | 510K submitted for third breakthrough device; CMS finalized favorable DRG increases. |
| Commentary | Shifting from a sacro-pelvic leader to a broader spinal-pelvic compromised bone company. |
| New Launches | Third breakthrough device launch planned for Q4 2026, potentially October. |
Growth
Worldwide revenue grew 15.2% to $56M; U.S. procedure volume increased 15% with double-digit growth across all modalities.
Outlook
Raised 2026 revenue floor to $231M-$233M; targeting 100 territory managers and phased Q4 breakthrough device launch.
Risks
Management pivoted to 'thoughtful guidance philosophy' when questioned on implied H2 U.S. revenue deceleration despite new catalysts.
The company's earnings call, NASDAQ: SIBN, and its 8-K filed with the SEC. Summary written with AI assistance from the call.
Earnings call webcast ↗ Watch on YouTube ↗
SI-BONE, Inc.: key numbers
- Share price
- $23.41Close, Nov 16
- Market cap
- $1.06B
- Shares outstanding
- 45.11MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from SI-BONE, Inc.
All →SI-BONE CEO Laura Francis Sells $1.9M of Stock
Laura Francis, CEO, sold 75,000 shares of SI-BONE, Inc. at $25.30 a share, worth $1.9M in total on Nov 4, 2026. Shares held after the trade: 304,256 (-19.8%).
- Value
- $1.9M
- Shares
- 75,000
- Price
- $25.30
- Role
- CEO
- Holding change
- -19.8%
- Trade date
- Nov 4, 2026
SI-BONE SVP, Ops & Adm/Chief Legal Ofr Michael A. Pisetsky Sells $899K of Stock
Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr, sold 36,241 shares of SI-BONE, Inc. at $24.80 a share, worth $899K in total on Nov 4, 2026. Shares held after the trade: 40,167 (-47.4%).
- Value
- $899K
- Shares
- 36,241
- Price
- $24.80
- Role
- SVP, Ops & Adm/Chief Legal Ofr
- Holding change
- -47.4%
- Trade date
- Nov 4, 2026
SI-BONE Chief Op & Financial Officer Anshul Maheshwari Sells $81.2K of Stock
Anshul Maheshwari, Chief Op & Financial Officer, sold 3,247 shares of SI-BONE, Inc. at $25.00 a share, worth $81.2K in total on Nov 4, 2026. Shares held after the trade: 211,250 (-1.5%).
- Value
- $81.2K
- Shares
- 3,247
- Price
- $25.00
- Role
- Chief Op & Financial Officer
- Holding change
- -1.5%
- Trade date
- Nov 4, 2026
SI-BONE Director Jeffrey W. Dunn Sells $418K of Stock
Jeffrey W. Dunn, Director, sold 20,000 shares of SI-BONE, Inc. at $20.89 a share, worth $418K in total on Nov 2, 2026. Shares held after the trade: 16,057 (-55.5%).
- Value
- $418K
- Shares
- 20,000
- Price
- $20.89
- Role
- Director
- Holding change
- -55.5%
- Trade date
- Nov 2, 2026
SI-BONE Q3 2026 Results: Net Loss of $3.62M, Loss Narrows
SI-BONE, Inc. reported revenue of $55.7 million for the third quarter of 2026, representing a 14.5% increase over the same period in 2025. The company reduced its quarterly net loss to $3.6 million compared to $4.6 million in the prior year, driven by improved gross margins and controlled operating expense growth.
- Key figure
- Net loss $3.62M
SI-BONE SVP, Ops & Adm/Chief Legal Ofr Michael A. Pisetsky Sells $656K of Stock
Michael A. Pisetsky, SVP, Ops & Adm/Chief Legal Ofr, sold 29,665 shares of SI-BONE, Inc. at $22.11 a share, worth $656K in total on Oct 29, 2026. Shares held after the trade: 164,444 (-15.3%).
- Value
- $656K
- Shares
- 29,665
- Price
- $22.11
- Role
- SVP, Ops & Adm/Chief Legal Ofr
- Holding change
- -15.3%
- Trade date
- Oct 29, 2026